Merck
Merck receives CE Mark approval for new liquid biopsy test for colorectal cancer
April 6, 2016Medical Communications, Research and Development, Sales and Marketing CE Mark, Merck, biomarker, biopsy, colorectal cancer, liquid biopsy, ras, sysmex inostics
Merck (ETR: MRK) has announced that their new liquid biopsy RAS biomarker test for metastatic colorectal cancer, developed in collaboration …
OncoMed initiates Phase Ib immuno-oncology combination clinical trial
March 18, 2016Medical Communications, Research and Development Merck, OncoMed, clinical trial, demcizumab, immuno-oncology, immuno-oncology combination, pembrolizumab, phase ib
OncoMed (NASDAQ: OMED) has announced the beginning of its Phase Ib clinical trial to investigate if the combination of demcizumab …
Merck chief executive Karl-Ludwig Kley to step down in April
March 9, 2016Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley
It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Merck announces drug discovery collaboration with European Molecular Biology Laboratory
March 3, 2016Research and Development Cancer, Merck, biomarkers
Merck has announced that it has entered into a research collaboration with the European Molecular Biology Laboratory (EMBL), that will …
Merck begins late-stage trials of Humira biosimilar
March 2, 2016Research and Development, Sales and Marketing AbbVie, Humira, Merck, biosimilars
Merck has announced the beginning of a global phase III study of its Humira (adalimumb) biosimilar, MSB11022, in chronic plaque …
Merck partners with Ugandan Health Ministry to tackle cancer awareness
February 8, 2016Manufacturing and Production, Medical Communications Africa, Cancer, Merck
Germany’s Merck celebrated World Cancer Day by collaborating with the Uganda Ministry of Health to raise awareness about early detection …
New biopharma heads for Merck in North America and China
January 27, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gary Zieziula, Mark Horn, Merck
Merck has made two appointments in its biopharma business: Gary Zieziula will lead Merck’s biopharma business in North America and …
Merck appoints Jessie English to lead discovery team
January 22, 2016Research and Development Jessie English, Merck
Merck has appointed Jessie English as the new vice president of discovery, translational innovation platform immuno-oncology, effective February 16, 2016. …
Merck appoints new executive board members
January 19, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck
Merck has appointed two new members to its executive board: Udit Batra (45), head of the Life Science business sector, …
MSD sues German Merck for using name in US
January 15, 2016Medical Communications, Sales and Marketing MSD, Merck
MSD says it is filing a lawsuit against the German company Merck “regarding their improper use of the name ‘Merck’ …
MSD to acquire Scottish firm IOmet Pharma
January 12, 2016Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology
US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …
Merck and Biocartis partner on new biomarker test for colorectal cancer
January 7, 2016Research and Development BRAF mutations, Diagnostics, Erbitux, Merck, RAS metations, diagnostic tests, metastic colorectal cancer
Merck has signed a collaboration agreement with diagnostics company Biocartis for the development and commercialisation of a new test for …
Pfizer, Merck and Syndax in ovarian cancer trial collaboration
January 5, 2016Manufacturing and Production, Research and Development Merck, Pfizer, Syndax Pharmaceuticals, avelumab, entinostat, ovarian cancer
Pfizer, Merck and Syndax Pharmaceuticals have announced a collaboration to test avelumab, in combination with Syndax’s entinostat, in patients with …
Merck’s Erbitux approved for NHS Wales
January 5, 2016Manufacturing and Production, Sales and Marketing Erbitux, Merck, cetuximab, colorectal cancer, metastatic colorectal cancer
The All Wales Medicines Strategy Group has recommended Merck’s Erbitux in combination with chemotherapy for restricted use in the NHS …
Merck and Pfizer kick off Phase III avelumab cancer trials
December 23, 2015Research and Development Merck, Pfizer, avelumab, ovarian cancer
Merck and Pfizer have announced the opening of trial sites for an international Phase III study of avelumab in patients …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
